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ABSTRACT
Phenylpropanoids, such as flavonoids and stilbenoids, are of great commercial interest, and their production in
Saccharomyces cerevisiae is a very promising strategy. However, to achieve commercially viable production, each step of the
process must be optimised. We looked at carbon loss, known to occur in the heterologous flavonoid pathway in yeast, and
identified an endogenous enzyme, the enoyl reductase Tsc13, which turned out to be responsible for the accumulation of
phloretic acid via reduction of p-coumaroyl-CoA. Tsc13 is an essential enzyme involved in fatty acid synthesis and cannot
be deleted. Hence, two approaches were adopted in an attempt to reduce the side activity without disrupting the natural
function: site saturation mutagenesis identified a number of amino acid changes which slightly increased flavonoid
production but without reducing the formation of the side product. Conversely, the complementation of TSC13 by a plant
gene homologue essentially eliminated the unwanted side reaction, while retaining the productivity of phenylpropanoids
in a simulated fed batch fermentation.
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INTRODUCTION
Phenylpropanoids and their flavonoid derivatives are natural
constituents of the common human diet (Yao et al. 2004). They
are also commercially interesting and frequently marketed and
used as dietary supplements (Chun, Chung and Song 2007; Vi-
dak, Rozman and Komel. 2015), food colourants (He and Giusti
2010), and preservatives (Balasundram, Sundram and Samman
2006). Flavonoids are present in most plants, including berries,
fruits and vegetables used for human consumption. In planta,
these compounds serve several functions such as signalling, pig-
mentation, UV and pathogen protection, as well as providing
plants with structural integrity (Ferrer et al. 2008; Falcone Fer-
reyra, Rius and Casati 2012). In humans, numerous reports have
linked them to health benefits due to various biological activities
(recently reviewed by Yao et al. 2004; Tapas, Sakarkar and Kakde
2008; Lu, Xiao and Zhang 2013).
Current commercial production of flavonoids relies almost
exclusively on extraction from plants, which makes the pro-
cess dependent on stable supplies of good quality raw materi-
als. Furthermore, a number of interesting flavonoids are found
only in rare plants, which may be difficult to access, or occur
only in minute concentrations or in mixtures with similar com-
pounds, making their isolation and purification difficult (Hatano
et al. 2000; Yu et al. 2016). As an alternative, organic synthe-
sis is also challenging since in many cases a mix of stereoiso-
mers is produced and, hence, toxic solvents may be needed dur-
ing the catalysis or purification processes (Fowler and Koffas
2009). As a response to these obstacles, the use of microorgan-
isms as cell factories for industrial production is gaining popu-
larity, and as such the yeast Saccharomyces cerevisiae has already
been used, not only for production of flavonoids but also for a
wide spectrum of products including e.g. fuels, pharmaceuti-
cals, food ingredients and other chemicals (Abbott et al. 2009;
Keasling 2010; Hong and Nielsen 2012; Peralta-Yahya et al. 2012;
Nielsen et al. 2013). Hence, the use of yeast for commercial pro-
duction of flavonoids would seem to offer an excellent opportu-
nity, being well suited for large-scale fermentation (Wang et al.
2011; Baerends et al. 2015; Katz et al. 2015; Trantas et al. 2015).
The flavonoid biosynthetic pathway in plants starts with
the conversion of L-phenylalanine into trans-cinnamic acid
through the non-oxidative deamination by phenylalanine am-
monia lyase (PAL). Next, trans-cinnamic acid is hydroxylated at
the para position to p-coumaric acid (4-hydroxycinnamic acid)
by cinnamate-4-hydroxylase (C4H). C4H is a cytochrome P450
monooxygenase, needing regeneration by a cytochrome P450 re-
ductase (CPR). Alternatively, the amino acid L-tyrosine can be
converted into p-coumaric acid by tyrosine ammonia lyase (TAL).
P-Coumaric acid is subsequently activated to p-coumaroyl-CoA
by the 4-coumarate-CoA ligase (4CL). From here it branches out
to give rise to flavonoids, stilbenoids, curcuminoids, lignins, etc.
(Weisshaar and Jenkins 1998). In the case of most flavonoids, a
chalcone synthase (CHS) and a chalcone isomerase (CHI) catal-
yse the condensation of p-coumaroyl-CoA with three molecules
of malonyl-CoA, resulting in the formation of naringenin chal-
cone and finally naringenin (Fig. 1) (Weisshaar and Jenkins 1998;
Ferrer et al. 2008). Naringenin represents a key branch point,
from which a large array of different flavonoids are synthesised.
Several studies have reported the production of naringenin
in Escherichia coli (Hwang et al. 2003; Leonard et al. 2007; San-
tos, Koffas and Stephanopoulos 2011; Wu et al. 2014). How-
ever, since cytochrome P450 monooxygenases and their cog-
nate reductases are not well expressed in bacteria (Hotze,
Schro¨der and Schro¨der 1995), a bacterial hostmaynot be optimal
depending on the desired end product. In yeast, Ro and Douglas
(2004) were the first to reconstruct the entry point of the plant
phenylpropanoid pathway, by co-expressing PAL, C4H and a CPR.
Building on these results, the naringenin biosynthetic pathway
has subsequently been efficiently expressed in yeast, showing
production titres close to those obtained in E. coli (Jiang, Wood
and Morgan 2005; Yan, Kohli and Koffas 2005; Trantas, Panopou-
los andVerveridis 2009; Koopman et al. 2012), thusmaking S. cere-
visiae a promising host for the production of phenylpropanoids
and flavonoids. Another important consideration regarding the
choice of production host is the ability to efficiently use cheap
carbon sources, and the ability to funnel the carbon into the de-
sired product. Thus, in addition to an optimised biosynthetic
pathway, it is essential that the host metabolism can be adapted
to the heterologous production during fermentation, and that
undesired by-product formation, resulting in carbon loss, can
be eliminated (Nevoigt 2008; Hong and Nielsen 2012). Previous
reports using S. cerevisiae for expression of flavonoid pathways
have described accumulation of such undesired by-products.
In particular, several studies reported a significant accumula-
tion of phloretic acid (dihydrocoumaric acid) (Beekwilder et al.
2006; Koopman et al. 2012; Luque et al. 2014; Vos et al. 2015)
and in one case also phloretin (dihydrochalcone, DHC), a di-
rect derivative of phloretic acid (Jiang, Wood and Morgan 2005).
These authors speculated that phloretic acid is derived from
p-coumaroyl-CoA in two steps: p-coumaroyl-CoA is first reduced
to dihydro-coumaroyl-CoA by an unknown yeast reductase(s)
and then dihydro-coumaroyl-CoA is hydrolysed, either sponta-
neously or by another unknown enzymatic reaction (Beekwilder
et al. 2006; Koopman et al. 2012).
This hypothesis fits well with what is known from plants,
in particular apples (Malus domestica), where phlorizin, the
2′-glucoside of phloretin, is the major phenolic compound.
The biosynthetic pathways of these compounds have been
studied in some detail. Formation of phloretin depends on
CoA-activated phloretic acid which in turn is the result of a
p-coumaroyl-CoA double-bond reduction. Gosch et al. (2009)
determined that incubation of p-coumaroyl-CoA with NADPH
and an enzyme preparation from young apple leaves resulted
in the formation of dihydro-coumaroyl-CoA. They proposed
that dihydro-coumaroyl-CoA is synthesised from p-coumaroyl-
CoA by an unknown NADPH-dependent double-bond reductase
(DBR) (Fig. 1). Based on similarities to the enoyl reduction steps
in fatty acid biosynthesis, they suggested a side activity of a
fatty acid dehydrogenase to be involved. Based on these pre-
vious studies, in both yeast and plants, we decided to screen
the Yeast Knock Out (YKO) collection for NAD(P)H-dependent
reductases, with the aim of identifying the enzymatic activ-
ity responsible for phloretic acid formation in yeast. We iden-
tified Tsc13 as the main contributor to this activity, and then
tested two different approaches aimed at reducing or elimi-
nating the loss of carbon in this side reaction of the flavonoid
pathway.
MATERIALS AND METHODS
Chemicals
Trans-cinnamic acid (CAS nr.: 140-10-3), p-coumaric acid (CAS
nr.: 501-98-4), phloretic acid (CAS nr.: 501-97-3), naringenin (CAS
nr.: 67604-48-2) and dihydro-cinnamic acid (CAS nr.: 501-52-
0) were obtained from Sigma Aldrich, Copenhagen, Denmark.
Phloretin (CAS nr.: 60-82-2) was obtained from Extrasynthese,
Genay Cedex, France.
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Figure 1. General phenylpropanoid pathway from phenylalanine to p-coumaroyl-CoA, where it branches out to flavonoids, stilbenoids, etc. The pathway to the key
intermediate naringenin is shown. The DBR activity instead gives rise to DHCs. DBR, double-bound reductase; PAL, phenylalanine ammonia lyase; C4H, cinnamate-4-
hydroxylase; CPR, cytochrome P450 reductase; TAL, tyrosine ammonia lyase; 4CL, 4-coumarate-CoA ligase; CHI, chalcone isomerase; CHS, chalcone synthase.
Yeast strains, transformation and cultivation
Strains constructed for the expression of flavonoids were
derived from a Saccharomyces cerevisiae derivative of S288c
(National Collection of Yeast Cultures, Norwich, UK, NCYC
3608). The YKO strains (Winzeler et al. 1999) were selected from
the YKO collections YSC1056 and YSC1057 obtained from Open
Biosystems, (Huntsville, Madison, Alabama, USA) now part of
Dharmacon (GE Health), http://dharmacon.gelifesciences.com/
non-mammalian-cdna-and-orf/yeast-knockout-collection.
From the YKO library, all NAD(P)H-dependent reductases
and oxidoreductases with known substrate specificity were
evaluated, and a total of 26 enzymes were selected based on
structural similarity of their substrates to p-coumaroyl-CoA,
e.g. the presence of enoyl double bonds. Most of the YKOs were
homozygous diploids; however, for essential genes YKOs were
obtained as heterozygous diploids (Table 1). Since an original
wt is not provided with the YKO collection, the experiment was
run without a genuine control strain, and strains were instead
compared to each other based on relative production levels.
All yeast transformations were done using standard Li-
acetate methods according to Gietz and Schiestl (2008). Trans-
formed yeast cells were selected on synthetic complete (SC)
medium lacking uracil (SC-Ura) (Illkirch Cedex, France, MP
Biomedicals).
For each strain tested, six colonies were inoculated in 0.5 mL
SC-Ura and incubated overnight at 30◦C and 400 rpm in 96 well
deep well plates (DWP). The following day, 50 μL of each culture
was transferred into 0.5 mL of fresh SC medium or, for YKO li-
brary screening, into SCmedium containing 5 μL of 100mgmL−1
p-coumaric acid in 96% ethanol. The transformants were then
incubated for 96 h at 30◦C and 400 rpm in 96 well DWP.
To test the production of phenylpropanoids in strains where
TSC13 had been substituted by homologous genes, the cells were
cultivated in synthetic feed-in-time (FIT) fed-batch medium
Table 1. Selected NAD(P)H-dependent yeast oxidoreductases
screened in this study (Winzeler et al. 1999).
Genotype Systematic name
oye2/oye2 YHR179W
ylr460c/ylr460c YLR460C
adh7/adh7 YCR105W
ydr541c/ydr541c YDR541C
gre2/gre2 YOL151W
adh6/adh6 YMR318C
yml131w/yml131w YML131W
ymr226c/ymr226c YMR226C
oye3/oye3 YPL171C
ypl088w/ypl088w YPL088W
aad4/aad4 YDL243C
aad6/aad6 YFL056C
dfg10/dfg10 YIL049W
zta1/zta1 YBR046C
ari1/ari1 YGL157W
aad3/aad3 YCR107W
frd1/frd1 YEL047C
shh3/shh3 YMR118C
osm1/osm1 YJR051W
lot6/lot6 YLR011W
ayr1/ayr1 YIL124W
yjr096w/yjr096w YJR096W
ydl124w/ydl124w YDL124W
TSC13/tsc13 YDL015C
SDH3/sdh3 YKL141W
ERG27/erg27 YLR100W
(Baesweiler, Germany, m2p-labs) for 72 h at 30◦C and 200 rpm
in 24 well DWP. FIT medium was prepared according to the
manufacturer’s instructions and then supplemented with the
supplied vitamin solution (final concentration 1% v/v), and the
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Table 2. Genes, accession numbers, EC numbers and source
organism.
Gene Accession no EC number Organism
AtPAL2 NP 190894 4.3.1.24. Arabidopsis thaliana
AtC4H NM 128601 1.14.13.11. Arabidopsis thaliana
AtATR2 NP 849472 1.6.2.4. Arabidopsis thaliana
PhCHI P11650 5.5.1.6. Petunia hybrida
HaCHS Q9FUB7 2.3.1.74. Hypericum androsaemum
At4Cl NP 188761 6.2.1.12. Arabidopsis thaliana
MsCHI P28012 5.5.1.6. Medicago sativa
AtECR NP 191096 1.3.1.93. Arabidopsis thaliana
GhECR2 ABV60089 1.3.1.38. Gossypium hirsutum
MdECR XP 008382818 1.3.1.93. Malus domestica
AtPAL1 L33677 4.3.1.24. Arabidopsis thaliana
AnPAL1 A2QIQ7 4.3.1.24. Aspergillus niger
RtPAL P11544 4.3.1.25. Rhodosporidium toruloides
enzyme mix (final concentration 0.8% v/v) prior to use. Control
strain used was BLY2 with an empty pRS416-GPD plasmid (de-
scribed in Mumberg, Mailer and Funk 1995).
To test the growth of strains, they were cultivated in SC
medium (2% glucose) for 72 h at 30◦C and 200 rpm in 24 DWP.
To confirm the results from the FIT batch experiment, a strain
with MdECR and a control strain (BLY2 with pRS416-GPD) were
cultivated in the synthetic fed-batch medium the (Baesweiler,
Germany, m2p-labs) is already provided above for 72 h at 30◦C
and 180 rpm in 100 mL shake flasks (total volume 25 mL). For
this experiment, FIT medium was prepared as described above
but 0.4% v/v of the enzyme mix was added at three time points:
immediately prior to use, at 22 h and at 46 h.
Plasmids and strains construction
Oligonucleotide primers used for cloning and verification of ge-
nomic integrations/deletions are listed in Tables S1–S3 (Support-
ing Information). All primers were synthesised by Integrated
DNA Technologies, Leuven, Belgium. Constructed plasmids are
listed in Tables S4–S6 (Supporting Information). Synthetic genes
were codon optimised for S. cerevisiae and obtained from Ge-
neArt (Naerum, Denmark, Thermo Fisher Scientific) (Table 2).
Classic and USER cloning techniques (Nour-Eldin et al. 2006)
were used. Cloning was performed using E. coli DH5α competent
cells, and transformantswere selected on Luria-Bertani (LB) agar
plates containing 100 mg mL1 of ampicillin.
Strains used for the reductase screening
For the YKO reductase screening, a plasmid coding for an in-
complete naringenin pathway (At4CL, MsCHI and HaCHS) was
assembled in vivo in the YKO strains using homologous recom-
bination tags, essentially as described by Kuijpers et al. (2013).
The fragments for the plasmid assembly were obtained by AscI
digestion of the plasmids indicated in Table S4 (Supporting In-
formation).
For the construction of BLY2 and BLY3 (Table 3), and strains
with partial flavonoid pathways, the plasmids (Table S5, Sup-
porting Information) were constructed as integrative Easy Clone
vectors according to Jensen et al. (2014). Integration of the
flavonoid pathway was done by homologous recombination as
described by Shao, Zhao and Zhao (2009). Basic backbones are
described by Mikkelsen et al. (2012), who also describes the tech-
niques used for plasmid construction. Three assembler plas-
mids were used for each integration, each having homology ei-
Table 3. Strains used in the present study, all based on S. cerevisiae
S288C.
BLY1
MATalpha, ho0, ura30::KanMX,
pad1-fdc10::LoxP-NatMX-LoxP, aro10::DR
BLY2 MATalpha, ho0, ura30::KanMX,
pad1-fdc10::LoxP-NatMX-LoxP, aro10::DR, X.2::DR
pTDH3-AtPAL2-tPGI1/TEF2-C4H L5 ATR2-tCYC1/pPGK1-
HaCHS-tENO2/pTEF1-PhCHI-tFBA1/pPDC1-At4Cl-tTDH2
BLY3 MATalpha, ho0, ura30::KanMX,
pad1-fdc10::LoxP-NatMX-LoxP, aro10::DR,
X.2::DR/pTDH3-AtPAL2-tPGI1/TEF2-C4H L5
ATR2-tCYC1/pPGK1-HaCHS-tENO2/pTEF1-PhCHI-
tFBA1/pPDC1-At4Cl-tTDH2, XI.2::DR pTDH3-AtPAL2-tPGI1/
pPGK1-HaCHS-tENO2, XVI-20::DR
pTDH3-AtPAL2-tPGI1/TEF2-C4H L5 ATR2-tCYC1/
pPGK1-HaCHS-tENO2, X-4::DR pTEF1-HaCHS-tCYC1,
X.3::DR/pTDH3-AtPAL2-tPGI1/pTEF2-AtPAL1-tCYC1/
pPGK1-HaCHS-tENO2/pTEF1-AnPAL1-tFBA1/pTPI1 AtPAL2
CO2-tADH1/pPDC1-RtPal -tTDH2, XI-5::DR/pTEF2-Ha
CHS co4-tCYC1/pPGK1-Ha CHS-tENO2/pTEF1-HaCHS co1-
tFBA1/pTPI1-HaCHS co5-tADH1/pPDC1-HaCHS co6-tTDH2,
XII.5::DR pTEF1-Aro4 K229L-tCYC1
ther to each other or to a specific region of the yeast genome.
Each of these plasmids already has terminator sequences, and
promoters and gene coding sequences were pre-cloned into
these plasmids by USER cloning (Nour-Eldin et al. 2006). The
KlURA3 marker on some of the integration vectors is flanked
by direct repeats (DR). The KlURA3 marker was looped out af-
ter each transformation round, by recombination between the
DRs and growing cells with 5-fluoroorotic acid (Lee and Da Silva
1997). Yeast genomic DNA was extracted according to Lo˜oke,
Kristjuhan and Kristjuhan (2011), and genomic integration of all
insertions/deletions was confirmed by PCR analysis.
The reductases Tsc13 and Dfg10 were overexpressed on the
multicopy plasmid pRS426-GPD (described in Mumberg, Mailer
and Funk 1995) in strain BLY3. Strain BLY3, accumulating p-
coumaric acid, was obtained by increasing the copy number of
PAL genes and by boosting the supply of endogenous aromatic
amino acids via the introduction of Aro4 K229L as described
by Mckenna et al. (2014). Control strain used was BLY3 with an
empty pRS426-GPD plasmid.
Strain for testing the TSC13 SSM library
Knockout of TSC13 results in non-viable cells due to its es-
sential role as described by Kohlwein et al. (2001). In order to
test tsc13 mutants, these were therefore introduced prior to
deleting TSC13. The collection of tsc13 mutants (site saturation
mutagenesis (SSM) library), plus awild-type (wt) control, was ini-
tially introduced episomally on the pRS416-GPD plasmid (Mum-
berg, Mailer and Funk (1995)), before deleting the native TSC13.
The TSC13 deletion cassette was constructed to contain the
bleomycin resistance gene (ble), flanked by 500 bp regions both
upstream and downstream of TSC13 (cloned in pROP671). A
naringenin producer strain comprising either thewt TSC13 (con-
trol) or the SSM library plasmid mix was transformed with 300
ng of the TSC13 deletion cassette.
Tsc13 homology modelling
Thehomologymodel of Tsc13was built based on the structure of
a trans-2-enoyl reductase from Homo sapiens (Protein Data Bank
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ID 1YXM; Jansson et al. submitted). An initial sequence align-
ment was completed using EMBOSS Water Pairwise Sequence
Alignment tool (Smith and Waterman 1981) using the standard
alignment settings and the Pearson FASTA output. The homol-
ogy model was constructed using the Homology Model tool in
MOE (MOE 2013) using default settings, including the Proto-
nate3D tool for placement of hydrogens and minimisation re-
finement of the final model with AMBER10:EHT force field. To
mimic the natural cofactor NADP+, the crystal structure tem-
plate 1YXM has an adenine molecule bound in the cofactor
site. However, there is no substrate bound (apo state). Therefore,
a hexanoyl-CoA substrate was modelled into the active site by
superimposing the Tsc13 homology model on the active sites
of 1YXM and 1W6U (Alphey et al. 2005) using PyMol [PyMol].
Based on the resulting model, residues predicted to be within
4.5 A˚ from the putative active site were selected for mutagene-
sis.
SSM library screening
A total of 25 amino acids were predicted to be in the re-
gion of the Tsc13 active site: Arg8, Lys30, Phe62, Phe89, Cys90,
Glu91, Tyr92, Leu93, Leu97, Val98, His99, Ser100, Leu101, Phe102,
Leu105, Tyr138, Glu144, Gln150, Phe151, Thr155, Tyr182, Tyr219,
Cys220, His221 and Ile222. The total TSC13 SSM library, produced
by MAX randomisation (Nov 2012), was ordered from GeneArt
(Thermo Fischer Scientific) and cloned into a pRS416-GPD plas-
mid. Approximately 30 000 primary transformants from the SSM
library were collected and subjected to TSC13 deletion. Approx-
imately 10 000 colonies, selected for deletion of wt TSC13, were
obtained of which 3786 were finally tested. This number was
derived from a calculation including a couple of assumptions
and based on the work of Nov (2012). Briefly, we aimed to have
a theoretical chance of 99.99% of finding one of the two best
(K = 2) amino acids for each position that was mutated. Using
the MAX randomisation, in which all amino acids are equally
represented, the number of clones to screen was calculated ac-
cording to Nov (2012) as 88 clones for each of the 25 mutations
(http://stat.haifa.ac.il/∼yuval/toplib/). This number was further
adjusted for an estimated knock-in efficiency of 70% (the ratio
of clones with correct exchange of the TSC13 wt gene with a
mutant) and a ratio of 83% correct mutant genes obtained from
gene synthesis (as reported by the supplier). Hence the number
of clones to screen was calculated as 25∗88/(0.70∗0.83) = 3786.
All clones were analysed by HPLC for production of p-
coumaric acid, phloretic acid and naringenin. Two controls with
wt TSC13 and two controls with only empty pRS416-GPD plas-
mids were included in each of the test units (96 well DWP). Mu-
tants that displayed alterations in production patterns relative
to the wt (average phloretic acid at least 20% lower or average
naringenin at least 20% higher), were re-tested for production
of phenylpropanoids, confirmed for TSC13 deletion, and finally
the plasmid harbouring the mutated tsc13 was isolated and se-
quenced.
Introduction of TSC13 plant homologues
The native open reading frame (ORF) of TSC13 was replaced by
gene homologues from Arabidospis thaliana (AtECR), Gossypium
hirsutum (GhECR2) andMalus domestica (MdECR), according to the
method described by Fairhead et al. (1996) using a split URA3
cassette. The homologues were under the control of the native
TSC13 promoter. The split URA3 cassettes were amplified by PCR
using the primers listed in Table S3 (Supporting Information).
The PCR fragments used to create the split URA3 cassettes were
stitched together by the USER enzyme (Kildegaard et al. 2016),
further ligated and finally PCR amplified. After transformation,
correct insertion of the homologues was verified by PCR (using
primers RES1056 TSC13 UP and RES1061 TSC13 DW) and further
confirmed by sequencing of the PCR fragment.
Sample preparation and analytical methods
The optical density (OD) was measured at 600 nm in cuvettes
using classical spectrophotometer or in MTP 96 microplates us-
ing an EnVision 2104 Plate Reader. For compound quantification,
100μL fromeach culturewas combinedwith 100μL 96% ethanol,
whirl mixed for 30 s at 1500 rpm and centrifuged for 10 min at
4000 × g. Supernatants were analysed by HPLC.
Phloretic acid, p-coumaric acid, cinnamic acid, dihydrocin-
namic acid, naringenin and phloretin were measured at 225 nm
using an Ultimate3000 HPLC with an Ultra C18 3μm Column
(100 × 4.6 mm) operating at 40◦C, coupled to a diode array
detector. Solvent A was water and solvent B was acetonitrile,
both containing 50 ppm trifluoroacetic acid. The flow rate was
1 mL/min with acetonitrile increasing from 20% at 0 min to 60%
in 9 min.
RESULTS
Confirming the phenylpropanoid substrate of the
endogenous reductase
The aim of this study was to identify the reductase respon-
sible for the formation of phloretic acid in Saccharomyces cere-
visiae and to obtain a strain capable of producing naringenin
without accumulating phloretic acid. Hence, we first wanted
to confirm p-coumaroyl-CoA as the intermediate being con-
verted into phloretic acid. We constructed a small collection of
yeast strains which expressed various enzymes of the phenyl-
propanoid pathway. We observed phloretic acid formation in a
strain expressing AtPAL, AtC4H, AtCPR and At4CL, but not in
strains expressing either AtPAL alone or AtPAL together with
AtC4H and AtCPR (Fig. S1, Supporting Information). This indi-
cated that p-coumaroyl-CoA, and not p-coumaric acid, is the ac-
tual substrate of the unknown yeast endogenous reductase, in
agreement with what was suggested by Beekwilder et al. (2006)
and Koopman et al. (2012). In a strain expressing only AtPAL and
At4CL, we observed formation of dihydro-cinnamic acid, in ad-
dition to the presumed precursor cinnamic acid. In contrast, a
strain expressing only AtPAL produced only cinnamic acid. This
demonstrated that also cinnamoyl-CoA is a substrate for the en-
dogenous reductase (Fig. S1).
Screening for an endogenous p-coumaroyl-CoA DBR
To narrow in on the endogenous activity responsible for
phloretic acid formation, we looked at publicly available infor-
mation about yeast enzymes. We assumed that the enzyme
would be an NAD(P)H-dependent reductase, based on previous
in vitro results with plant extracts (Gosch et al. 2009), and we
then further looked for enzymes of which the reported substrate
showed some structural similarity to p-coumaroyl-CoA. From
previous work in our labs, we also knew that overexpression of
FAS1/FAS2 does not change the level of phloretic acid in strains
expressing AtPAL and At4CL, so we excluded these enzymes.
Hence, based on the above criteria, a collection of 26 genes were
selected and the corresponding strains from the YKO collection
were transformedwith a plasmid carrying 4-coumarate-CoA lig-
ase (At4CL) and cultivated for 96 h in medium supplemented
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Figure 2. Concentrations of p-coumaric acid remaining (orange) and phloretic acid produced (gray) by different YKO strains after 96 h of growth in SCmedia containing
p-coumaric acid. Most knockouts were homozygous diploids with only TSC13/tsc13, SDH3/sdh3 and ERG27/erg27 tested as heterozygous diploids. Error bars represent
standard deviation (n = 6).
with p-coumaric acid. We assumed that any loss of endogenous
reductase activity on the p-coumaroyl-CoA would lead to lower
production of phloretic acid. Therefore, instead of measuring p-
coumaroyl-CoA product formation, which requires special an-
alytical setup, we analysed the samples for consumption of p-
coumaric acid and for production of phloretic acid. Out of the
26 strains tested, two YKO strains, TSC13/tsc13 and dfg10/dfg10,
both consumed less p-coumaric acid and produced less phloretic
acid (Fig. 2).
Overexpression of TSC13 and DFG10 in a
naringenin-producing strain
As a next step,we overexpressed TSC13 orDFG10 in a yeast strain
which accumulates p-coumaroyl-CoA as an intermediate of the
naringenin pathway. This strain, BLY3, had been engineered to
improve the endogenous supply of aromatic amino acids, which
had inadvertently resulted in an unbalanced naringenin path-
way and, thus, in the accumulation of pathway intermediates.
In this strain, TSC13 or DFG10 was overexpressed on a multi-
copy 2μ plasmid and analysed for any increase in the produc-
tion of phloretic acid. The strain overexpressing DFG10 showed
no change in the level of phloretic acid, p-coumaric acid or narin-
genin. In contrast, the strong overexpression of TSC13 resulted
in a clear increase in the level of phloretic acid and the appear-
ance of the derivative phloretin. Interestingly, this was mirrored
by a sharp decrease in the naringenin concentration (Fig. 3). This
was somewhat surprising since the level of p-coumaric acid, a
direct precursor of naringenin chalcone/naringenin, remained
unchanged. However, the observed compound levels might be
explained by 4CL and/or CHS being rate limiting in the current
strain. Thus, a constant level of p-coumaric acid may simply re-
flect a limitation in 4CL activity, with both Tsc13 and CHS being
active only on the CoA activated compound. With these two en-
zymes competing for p-coumaroyl-CoA, the overexpression of
Tsc13 would therefore leave less substrate for naringenin pro-
duction. The increased pool of CoA activated dihydro-coumaric
acid (phloretic acid) either dissociates to give rise to the observed
Figure 3. Phenylpropanoid production profile (p-coumaric acid (orange),
phloretic acid (grey) naringenin (red) and phloretin (black)) in BLY3, overex-
pressing TSC13 or DFG10 on multicopy plasmid pRS426-GPD. Control strain is
BLY3 with pRS426-GPD empty plasmid. Error bars represent standard deviation
(n = 6).
increase in phloretic acid or is used by CHS to produce phloretin.
With CHS being limiting that would further decrease the pro-
duction of naringenin. In any case, the results clearly showed
that Tsc13 is the main enzyme responsible for reduction of p-
coumaroyl-CoA while Dfg10 plays only a minor role.
Modelling the active site of Tsc13 for SSM screening
TSC13 is an essential gene, but we speculated whether it would
be possible to engineer the corresponding enzyme, and thereby
eliminate the non-specific activity on p-coumaroyl-CoA while
maintaining its native activity. While a six-membrane-spanning
topology, embedded in the ER membrane, has been proposed
for yeast Tsc13 (Paul, Gable and Dunn 2007), there is, to our
knowledge, no crystal structure or three-dimensional homol-
ogy model of the enzyme available. Hence, we decided to cre-
ate such a homology model in order to predict the active site
of Tsc13. As Tsc13 contains a C-terminal 3-oxo-5α-steroid 4-
dehydrogenase domain, the crystal structure of a similar pro-
tein, the 1YXM trans-2-enoyl CoA reductase, was selected as a
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Figure 4. Phenylpropanoid production profile (p-coumaric acid (orange),
phloretic acid (grey), naringenin (red)) in the naringenin-producing strain, where
native TSC13was replaced by different tsc13mutants. Control strain is BLY2with
pRS416-GPD empty plasmid. Error bars represent standard deviation (n = 5). For
statistical analysis, one-way ANOVA was used and the threshold of significance
for the p value was 0.05. For all values significantly different than the control the
bar are marked with asterisk.
basis for the model. For validation, the resulting Tsc13 homol-
ogy model was submitted to the DALI server (http://ekhidna.
biocenter.helsinki.fi/dali server, Holm and Rosenstro¨m, Nucleic
Acids Research, 2010, W545-W549) to search for known proteins
with similar structures. The top 12 hits included chainsA-D from
1YXM, but also 4FC6 and 4FC7 which have known trans-2-enoyl
CoA reductase activity.
Based on the model, 25 residues predicted to be within
4.5 A˚ from the putative active sitewere selected formutagenesis:
Arg8∗, Lys30∗, Phe62∗, Phe89, Cys90∗, Glu91, Tyr92, Leu93, Leu97,
Val98, His99, Ser100, Leu101, Phe102, Leu105, Tyr138∗, Glu144,
Gln150, Phe151∗, Thr155∗, Tyr182∗, Tyr219, Cys220∗, His221∗ and
Ile222. Residues marked with an asterisk are predicted to be
involved in binding of both the substrate and the co-factor
NAD(P)H. These residues were then subjected to SSM and the li-
brary of mutants was cloned into a single copy yeast expression
vector. The mutant library was introduced into the naringenin-
producing strain, BLY2, before mass deletion of the native TSC13
gene.
To ensure a reasonable coverage of the SSM library, a total of
3786 clones were analysed for growth and metabolite produc-
tion. This resulted in 18 clones which were confirmed both in
terms of their altered phenylpropanoid production profile and
for deletion of wt TSC13. Each specific tsc13mutationwas identi-
fied by sequencing. This narrowed down the number of specific
mutations to nine different substitutions, involving five differ-
ent positions. The level of phloretic acid was slightly lowered in
case of L101 T, E 144C andH221C,whereas the level of naringenin
was elevated in all mutants except L101 T and H221C (Fig. 4). We
speculate that this increase might in fact be due to a reduced
activity of the tsc13 mutants on p-coumaroyl-CoA, thus leaving
more substrate available for naringenin formation.
Complementation of Tsc13 by plant homologues
An alternative way to circumvent unwanted phloretic acid for-
mation would be the substitution of Tsc13 with an enzyme
which is able to complement its normal function, but does
not show activity on p-coumaroyl-CoA. Complementation of a
non-functional Tsc13 with plant homologues from Arabidospis
thaliana (AtECR) and Gossypium hirsutum (GhECR2) has been de-
scribed previously (Gable et al. 2004; Paul, Gable and Dunn 2007;
Song et al. 2009). In addition, a collection of TSC13 gene homo-
logues from plants which were overexpressed in yeast did not
exhibit any noticeable effect on phloretin production, suggest-
ing a lack of DBR activity on p-coumaroyl-CoA (Eichenberger
et al. 2017). Based on these complementation and overexpres-
sion studies, we selected three homologues—A. thaliana AtECR,
G. hirsutumGhECR2 andMalus domesticaMdECR—in order to eval-
uate their ability to complement TSC13 in yeast, without in-
terfering with the heterologous naringenin pathway. DNA se-
quences encoding each of the three homologues were inserted
in place of the TSC13 ORF into the yeast genome by homolo-
gous recombination, thus placing these homologues under the
control of the native regulatory sequences. The production of
phloretic acid, p-coumaric acid and naringenin was evaluated
in small-scale (DWP), fed-batch fermentation and, in addition,
the growth of these strains was tested during batch growth on
glucose.
Replacement of TSC13 with any of the three plant ho-
mologues AtECR, GhECR2 and MdECR resulted in viable cells,
demonstrating the ability to, at least partially, complement the
loss of Tsc13 cellular function. However, the growth in batch
fermentation was clearly affected, and final OD600 after 72 h
was substantially lower, reaching approximately 48%–55% com-
pared to the wt control for the GhECR2 andMdECR, and just a bit
more than 11% for the AtECR. The reduced biomass formation
appeared to depend on whether glucose or ethanol was used as
carbon source (Fig. S2, Supporting Information). Both GhECR and
MdECR resulted in only slightly reduced growth rates on glucose
(0.316 and 0.321 h−1, respectively, compared to 0.383 for the wt)
whereas after the diauxic shift, the growth on ethanol was seri-
ously impaired. In contrast, the AtECR strain grewpoorly on both
substrates (growth rate on glucose 0.096 h−1), and the formation
of crystals could be observed in the medium (Fig. S3, Support-
ing Information). We did not investigate further the nature and
composition of these crystals. The observed growth patterns are
likely a result of suboptimal production, in the complemented
strains, of the very long chain fatty acids (VLCFAs) which are
important for structure and function of membranes (Tehlivets,
Scheuringer andKohlwein 2007). In the study of Song et al. (2009),
the production of C26 fatty acids was shown to be reduced in
a yeast strain complemented by the GhECR2, associated with a
slight reduction in growth rate. A key point, demonstrated here
by the batch fermentation results, was the poor complementa-
tion during growth on ethanol.
In order to evaluate phloretic acid formation, the comple-
mented strains were regrown in DWP and, with the aim of
preventing formation and growth on ethanol, using a simu-
lated fed batch protocol based on the FIT enzymatic glucose
release. Strains were grown for 72 h and finally cultures were
analysed for production of flavonoid intermediates. In this fed
batch setup, the final ODs of the complemented strains, as
compared to the wt control, reached a relatively higher level
than what was seen for the batch cultures (Fig. S4, Support-
ing Information). More interestingly, no phloretic acid was de-
tected in the three strains complemented with plants homo-
logues, whereas the control strain (BLY2) accumulated large
amounts of this by-product (Fig. 5). Instead, the complemented
strains accumulated p-coumaric acid, part of which was fur-
ther metabolised to naringenin. Accumulation of p-coumaric
acid, as opposed to naringenin, was expected due to the lim-
ited CHS activity in the background BLY2 strain. In addition, the
supply of malonyl-CoA might have been negatively affected by
an impaired synthesis of VLCFAs, for example, via the resulting
accumulation of palmitoyl-CoA. This has previously been sug-
gested to cause feedback inhibition of malonyl-CoA formation
(Tehlivets, Scheuringer and Kohlwein 2007), which would then
8 FEMS Yeast Research, 2017, Vol. 17, No. 1
Figure 5. Production of flavonoid pathway intermediates (p-coumaric acid (or-
ange), phloretic acid (gray), naringenin (red) and phloretin (black)) in BLY2 where
TSC13 was replaced by homologous genes from three different organisms: A.
thaliana, AtECR; G. hirsutum, GhECR2; and M. domestica, MdECR. Control strain
is BLY2 with pRS416-GPD empty plasmid. Error bars represent standard devia-
tion (n = 3).
further reduce the production of naringenin. However, regarding
the final level of p-coumaric acid and the observed differences
between the three complemented strains, it is difficult to point
to a single obvious explanation. Since it is only partially corre-
lated to final OD, the reason(s) for this variation is unclear, but
could be a result of various stress reactions of the cell.
As the most promising candidate, the MdECR strain was
grown in 100 mL shake flask culture, in which the glucose re-
lease rate was further reduced, aiming to reach a final OD close
to the wt control. This resulted in the gradual accumulation
of p-coumaric acid and naringenin during 72 h (Fig. 6) in the
MdECR-expressing strain, while growth was only marginally ef-
fected, as compared to the control (Fig. 7). In contrast to the wt
control, which accumulated large amounts of phloretic acid, no
by-product formation was seen in the MdECR strain, similar to
our observation in the DWP experiment. Obviously, the rate of
converting p-coumaric acid to naringenin is still limiting and far
from optimal in this strain background. Nonetheless, the results
demonstrate the feasibility of using plant homologues for com-
plementing the Tsc13 in a controlled fermentation with slow
glucose release, thereby eliminating the unwanted side activity
of the native enzyme. The optimal growth rate for a commercial
production would of course need to be determined for a strain
with a fully optimised flavonoid pathway.
Figure 7. Growth of control strain BLY2 (black line with square marks) and the
strain where TSC13was replaced by the homologous geneMdECR fromM. domes-
tica (orange line with circle marks). The experiment was designed as described
in Figure 6. Error bars represent standard deviation (n = 3).
DISCUSSION
Production of small biochemical molecules by fermentation, us-
ing genetically engineered host strains such as yeasts and bac-
teria, has emerged as one of the most promising trends in the
recent quest for sustainable production methods. A major fac-
tor for achieving a commercially viable and successful fermen-
tation process is the stable supply of cheap and renewable raw
materials. An equally important factor is the efficient use of the
rawmaterial, which in terms of fermentationmeans a highly op-
timised production strain as well as a downstream process for
recovery of the product. In the current work, we focused on op-
timising a yeast host strain for production of phenylpropanoid-
derived compounds, with the specific goal of eliminating one
of the major side products, phloretic acid, associated with this
production.
Metabolic side reactions, such as the reduction of p-
coumaroyl-CoA, drain carbon from the compound of inter-
est. Hence, this enzymatic activity interferes with the indus-
trial production of relevant flavonoids and stilbenoids. That p-
coumaroyl-CoA is in fact the target for reduction had previously
been suggested (Beekwilder et al. 2006; Koopman et al. 2012), and
we confirmed this by showing that phloretic acid formation de-
pends on the expression of 4CL, the CoA ligase.
An initial screen of host reductases identified the enzymes
Tsc13 andDfg10 as possible candidates, involved in the phloretic
acid formation. TSC13 encodes an essential enzyme annotated
Figure 6. Production of flavonoid pathway intermediates (p-coumaric acid (orange), phloretic acid (gray), naringenin (red) and phloretin (black)) in BLY2 (A) and in the
strain where TSC13 was replaced by the homologous gene MdECR from M. domestica (B). The experiment was performed in shake flasks containing FIT media. Control
strain is BLY2 with pRS416-GPD empty plasmid. Standard deviation varied between 1.4% and 8% of the total value for each point (n = 3).
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Figure 8. Overlay model of the T92C mutation, affecting the interaction of p-
coumaroyl-CoA (cyan) with tyrosine (green) or cysteine (yellow) (A). Overlay
model of the P151G mutation, affecting the interaction of p-coumaroyl-CoA
(cyan) with phenylalanine (green) or glutamine (yellow) (B).
as a trans-2-enoyl-CoA reductase. It catalyses the reduction
of trans-2,3-enoyl-CoA intermediates in the elongation cycle
of VLCFAs (Kohlwein et al. 2001; Paul, Gable and Dunn 2007;
Wakashima, Abe and Kihara 2014). DFG10 encodes a putative
polyprenol reductase (Mo¨sch and Fink 1997). In a naringenin-
producing strain, overexpression of Tsc13, but not Dfg10, lead
to increased phloretic acid production, and a concomitant de-
crease in naringenin, which strongly suggested that Tsc13 is the
main enzyme responsible for the p-coumaroyl-CoA reductase
activity in yeast, and we therefore decided to focus on this en-
zyme in an attempt to reduce by-product formation.
As a first approach, we used SSM (Chronopoulou and Labrou,
2011) to engineer the native Tsc13 by mutagenesis. Based on in
silicomodelling of the putative catalytic site, 25 amino acidswere
mutated. Unfortunately, the SSM library did not turn up anymu-
tationswhich abolished phloretic acid production. Thismay be a
natural consequence of the fact that TSC13 is an essential gene,
and that major changes to the active site would be potentially
lethal. Thus,mutations conferring smaller changeswith less im-
pact were selected by this approach.
Most interesting was the increase of naringenin production
in several strains, while levels of phloretic and p-coumaric acids
showed only minor changes. As shown in Fig. 8A, the aromatic
ring of wt Y92 interacts with the carbonylic double bonds of CoA,
stabilising the p-coumaroyl-CoA conformation in the active site,
and this interaction is lost bymutation to C92 or T92. Also, in our
model, wt F151 interacts with the conjugated electron system of
p-coumaroyl-CoA, including the double bond to be reduced. Mu-
tation of this residue to E151 or S151 would disrupt this stabilis-
ing interaction (Fig. 8B). These mutations may therefore reduce
the affinity for p-coumaroyl-CoA, which in turn would make
more substrate available for CHS, leading to the observed in-
crease in naringenin. Regarding E144, it is not clear how mu-
tations at this residue would affect the structural environment
of the active site. Interestingly, all three residues are conserved
betweenTsc13 and the three plant homologues (Fig. S5, Support-
ing Information). We suspect that they are all essential for func-
tion at the active site, but that certain substitutions, which do
not disrupt the native function in fatty acid synthesis, are tol-
erated. This corresponds well with the findings of Paul, Gable
and Dunn (2007), who mutated several conserved residues to
alanine, without Tsc13 loss of function.
We believe the approach of using SSM to improve enzyme ac-
tivity is viable, but in our case a bettermodel or the crystal struc-
ture of the active site would be needed. Alternatively, a random
mutagenesis approach could be combined with a more efficient
screening assay. However, in the current study, we chose to not
continue this line of work.
As an alternative to mutagenesis, we tested the feasibility
of replacing the TSC13 gene with a plant homologue. One ra-
tionale for this approach was the fact that many plants are not
known to produce DHCs despite having a continuous supply of
p-coumaroyl-CoA. Thus, in these plants the enzymes involved in
fatty acid synthesis may be less promiscuous. Alternatively, ap-
ples and other plant species known to produce DHCsmight have
specific enzymes dedicated to the reduction of p-coumaroyl-
CoA, with other enoyl-reductases specific for fatty acid synthe-
sis. This would of course not, a priori, exclude the possibility that
the specificity for phenylpropanoids may have evolved from an
enoyl-reductase of the fatty acid synthesis system. In the cur-
rent study, we were interested in reductases that would not re-
duce p-coumaroyl-CoA while still being able to complement the
natural activity of Tsc13 in the synthesis of VLCFAs. We there-
fore focused on reductases with functional similarity to Tsc13
(categorised as an EC 1.3.1.93), and selected three plant homo-
logues from Arabidospis thaliana, Gossypium hirsutum and Malus
domestica.
Complementation of Tsc13 has been demonstrated previ-
ously by two of those enzymes: Gable et al. (2004) reported that
the AtECR homologue from A. thaliana (NP 191096) was able to
complement a temperature-sensitive yeast Tsc13 mutant, and
that it interacts with yeast Elo2 or Elo3, members of the VLCFA
synthase complex. Paul, Gable and Dunn (2007) determined that
AtECR has a membrane topology similar to Tsc13. We were able
to confirm the ability of AtECR to complement Tsc13, although
it did not seem to fully reconstitute function, as indicated by a
decrease in specific growth rate in batch fermentation. Chemi-
cal analysis of a yeast strain expressing this homologue showed
no phloretic acid production.
Another study has demonstrated complementation of Tsc13
in yeast by two homologues from cotton: GhECR1 (ABV60088)
and GhECR2 (ABV60089) (Song et al. 2009). This study showed
that GhECR1/2 were both present in the ER fraction, indicating
a cellular localisation similar to Tsc13. Both enzymes comple-
mented the Tsc13 KO strain when expressed on plasmids, but
whereas GhECR1 impaired growth substantially, GhECR2 did not
affect growth to any larger extent. In the current study, we con-
firmed the ability of GhECR2 to complement Tsc13, although
with more pronounced growth inhibition in batch fermentation
than what was reported earlier (Song et al. 2009). Also with this
homologue we detected no production of phloretic acid.
Finally, the apple enzyme MdECR (XP 008382818) was tested
in the current study. This enzyme was selected based on ho-
mology to AtECR and GhECR2 described above. Furthermore, it
had very high similarity to the ENRL-1, which was previously
found not to be involved in the production of DHCs (Dare et al.
2013). In the current study, the strain expressing the MdECR ho-
mologue showed the best performance in terms of naringenin
and p-coumaric acid production, and produced no phloretic acid.
Growth of the complemented strain was somewhat inhibited
when grown in batch cultivation. However, cultivating this strain
in a fed-batch fermentation clearly improved the growth, most
of all by preventing growth on ethanol.
In summary, all three plant homologues completely abol-
ished phloretic acid formation, albeit with different abilities to
complement native Tsc13. The growth inhibition we observed is
likely linked to the synthesis of VLCFAs. In yeast, a large frac-
tion of VLCFAs is used for the biosynthesis of sphingolipids and
phosphatidylinositol, important components of the cell mem-
brane, and disruption of Tsc13 is known to result in accumu-
lation of fatty acids shorter than 26 carbons (Kohlwein et al.
2001). Hence, incomplete complementation would lead to a defi-
ciency in these long fatty acids. In a study on cotton ECRs (Song
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et al. 2009), the strain complemented with GhECR2 showed a re-
duced level of VLCFAs compared to the wt strain, supporting
the notion that this could be the reason for the growth inhibi-
tion. Preliminary results from our labs, where we overexpressed
MdECR from amulticopy plasmid, indicated that further overex-
pression alone may not help. However, this could be due to the
fact that Tsc13 normally functions as part of a larger complex,
and that other components would also have to be overex-
pressed, or that interaction between these components, when
including a non-native enzyme, is not optimal. Alternatively, the
growth rate of a production strain might be adjusted to match
the turnover rate of the heterologous reductase, e.g. by an ap-
propriate fermentation process, which restores the balance of
VLCFA synthesis and the overall fatty acid profile. The results
from our shake flask fermentation (Fig. 7) appear to support this
idea.
CONCLUSION
The native yeast Tsc13 VLCFA enoyl-reductase was identified as
the main enzyme responsible for reducing heterologously pro-
duced p-coumaroyl-CoA. This side activity resulted in phloretic
acid accumulation and thereby, serious carbon loss in the
flavonoid biosynthetic pathway expressed in yeast.
Two different approaches to reduce this carbon loss were ex-
amined: mutation of native Tsc13 and replacement with a plant
homologue. In the first approach, we obtained small improve-
ments in the production of naringenin but were not able to elim-
inate the production of phloretic acid. In the second approach,
we demonstrated that complementation of Tsc13 by plant ho-
mologues can completely eliminate the side product formation.
The possible effects of this Tsc13 complementation on the
VLCFA synthesis machinery and the ensuing consequences of
altering the composition of fatty acid derived were not investi-
gated in this study, but would be an interesting subject for fur-
ther studies. Here we achieved at least partial restoration of VL-
CFA acid synthesis, since loss of C26 fatty acids is lethal to yeast,
and consequently we were able to do a fed-batch cultivation in
which the complemented strain exhibited growth rates compa-
rable to the wt Tsc13 strain. Obviously, for a final production
strain, the optimal feed rate, and thus the maximum achievable
growth rate, would have to be determined with an optimised
heterologous pathway. The goal would be to avoid growth on
ethanol, as is common in most fed-batch protocols, but also to
prevent any accumulation of fatty acid intermediates that could
disrupt the membrane structure and homeostasis, as well as
preventing feedback inhibition of precursors like malonyl-CoA
needed for flavonoid biosynthesis.
In short, we believe that, in particular, the latter approach is a
viable route toward reducing carbon loss to undesired phloretic
acid and, hence, for further optimisation of phenylpropanoid
production in yeast. In combination with an otherwise bal-
anced biosynthetic pathway, this should allow construction of
flavonoid-producing cell factories with no side product forma-
tion and, consequently, amore efficient and economic industrial
process.
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